roflumilast cream
Selected indexed studies
- Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials. (JAMA Dermatol, 2024) [PMID:39292443]
- Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials. (JAMA, 2022) [PMID:36125472]
- Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial. (Pediatr Dermatol, 2025) [PMID:39980188]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials. (2024) pubmed
- Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials. (2022) pubmed
- Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial. (2025) pubmed
- Roflumilast cream (Zoryve) for atopic dermatitis. (2024) pubmed
- Trial of Roflumilast Cream for Chronic Plaque Psoriasis. (2020) pubmed
- Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis. (2023) pubmed
- Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis-Reply. (2023) pubmed
- Efficacy and Safety of Roflumilast Cream in Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. (2025) pubmed
- Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials. (2025) pubmed
- Focused update: Guidelines of care for the management of atopic dermatitis in adults. (2025) pubmed